| abstract |
The present invention relates to changing the physical and / or chemical properties of at least a portion of at least one tissue of the eye. In certain embodiments, the present invention relates to the treatment and / or prevention of myopia. An activation energy source is used to photopolymerize or crosslink the molecules in the sclera, thereby increasing the strength of the tissue. A cross-linking reagent or photopolymerizable molecule associated with the membrane is administered to the individual and then precisely exposed to an energy source such as light or ultrasound. |